Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

Jacobs (United States) · Clifford Chance · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

One in 4 Americans >40 years of age takes a statin to reduce the risk of myocardial infarction, ischemic stroke, and other complications of atherosclerotic disease. The most effective statins produce a mean reduction in low-density lipoprotein cholesterol of 55% to 60% at the maximum dosage, and 6 of the 7 marketed statins are available in generic form, which makes them affordable for most patients. Primarily using data from randomized controlled trials, supplemented with observational data where necessary, this scientific statement provides a comprehensive review of statin safety and tolerability. The review covers the general patient population, as well as demographic subgroups, including the elderly,…

Citation impact

700
total citations
FWCI
80.19
Percentile
100%
References
372
Citations per year

Authors

15

Topics & keywords

Keywords
  • Medicine
  • Statin
  • Stroke (engine)
  • Population
  • Internal medicine
  • Diabetes mellitus
  • Myocardial infarction
  • Surgery
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.